News

/News

MILabs’ VECTor6 with groundbreaking PET performance awarded Innovation of the Year at the WMIC 2018

2018-09-18T16:41:29+00:00September 18th, 2018|News|

September 15, Seattle, USA MILabs is pleased to announce that its new VECTor6 with Broadband Photon Tomography technique has received the Commercial Innovation Award at the World Molecular Imaging Congress (WMIC) in Seattle September 12th-15th, 2018. The VECTor6 system advances the state of the art of PET imaging by increasing PET resolution down to 0.55 [...]

MILabs Broadband Photon Tomography nominated for Innovation of the Year – WMIC 2018

2018-09-11T09:17:09+00:00September 10th, 2018|News|

September 4, Seattle, USA, and Utrecht, the Netherlands MILabs is pleased to announce that its new Broadband Photon Tomography technique has been nominated for the Innovation of the Year 2018 award by the World Molecular Imaging Society (WMIS) board of trustees. Broadband Photon Tomography as implemented on MILabs’ new VECTor6 platform, dramatically expands the versatility and [...]

University of Sydney acquires state-of-the-art MILabs preclinical in-vivo X-ray CT

2018-09-05T12:27:31+00:00September 3rd, 2018|News|

Sydney, Australia, and Utrecht, the Netherlands, August 31st, 2018 MILabs announces that it has successfully completed the installation of its next-generation Adaptive U-CTXUHR at Sydney Imaging, a Core Research Facility of the University of Sydney. Recognizing that excellence in research is increasingly linked to excellence in infrastructure capability, Sydney Imaging selected MILabs X-ray CT system for [...]

Scientist in the Spotlight: Professor Vesna Sossi, Ph.D., TRIUMF Canada’s Particle Accelerator Centre

2018-09-04T15:20:15+00:00July 30th, 2018|News|

Professor Vesna Sossi, Ph.D. is blazing a trail with her theranostic research program at the University of British Columbia (UBC) and TRIUMF Canada’s Particle Accelerator Centre. As the director of the UBC Positron Emission Tomography (PET) Imaging Laboratory, Dr. Sossi and her colleagues are using the MILabs VECTor PET/SPECT/CT system to characterize and image isotopes in a [...]

The Hebrew University of Jerusalem installs MILabs’ dual-energy, high-resolution microCT for imaging drug delivery.

2018-09-04T15:25:36+00:00July 30th, 2018|News|

Jerusalem, Israel, and Utrecht, the Netherlands, July 30th, 2018 A MILabs dual-energy, ultra-high resolution U-CT system has been installed at the Hebrew University of Jerusalem Israel (HUJI). Under the direction of Professor Galia Blum, this institute has established an internationally renowned research program, focused on drug design, delivery, and therapy.  The Blum Lab uses synthetic [...]

MILabs announced the co-winners of the MILabs Image of the Year Award

2018-09-04T15:28:03+00:00July 12th, 2018|News|

This year MILabs had the pleasure to announce  two winners of the 2018 MILabs Image of the Year Award at the  SNMMI meeting in Philadelphia,  MILabs Founder and CEO  Prof. Dr. Freek Beekman presented these and other exciting  images at the Annual MILabs SNMMI Scientific Event, showcasing a wide diversity of user applications and the [...]

MILabs introduces futuristic PET capabilities on its new VECTor6 system

2018-09-04T15:31:07+00:00June 23rd, 2018|News|

The new VECTor6 imaging system is packed with exclusive preclinical PET imaging features including 0.6 mm 18F resolution,  the elimination of positron-range blurring for e.g. 124I, simultaneous multi-isotope PET and PET/SPECT tomography, and α- and β-radiotherapy imaging. Philadelphia, USA, June 23, 2018. At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26, [...]

MILabs launches the E-Class line of high-performance, economical PET, SPECT and, CT systems

2018-09-04T15:35:30+00:00June 8th, 2018|News|

Utrecht, The Netherlands, June 8th, 2018 Continuing its customer-centric approach, and fulfilling its commitment to providing preclinical imaging systems of unmatched price/performance, MILabs has introduced its E-Class of tomographic imaging products. The E-Class imagers were specifically designed for ambitious researchers to start their research now, and who want the option to easily upgrade the same [...]

Scientist in the Spotlight: Dr. Stephen Russell, M.D., Ph.D., Mayo Clinic, Rochester USA    

2018-09-04T15:43:41+00:00June 6th, 2018|News|

Dr. Stephen Russell is pioneering oncolytic virotherapy as a new modality for the treatment of cancer using state-of-the-art facilities at the Mayo Clinic in Rochester, including the preclinical U-SPECT/CT imaging system from MILabs. Dr. Russell was recruited to the Mayo Clinic from the University of Cambridge, UK, in 1998 to be the Director of a new virus [...]

Technical University Munich installs MILabs’ PET/SPECT/Optical/CT for translational imaging

2018-09-04T16:03:40+00:00May 29th, 2018|News|

Garching-Munich, Germany and Utrecht, the Netherlands, May 29th, 2018 A MILabs VECTor5PET/SPECT/OI/CT system has been installed at the Chair of Pharmaceutical Radiochemistry on the TUM Campus in Garching. Under the direction of Prof. Hans-Jurgen Wester, this institute has established a broad and internationally renowned radiopharmaceutical research program, consisting of fundamental tracer development, innovative radiolabeling strategies, [...]

MILabs installs new VECTor5CT at Italian’s prestigious Veneto Institute of Oncology

2018-09-04T16:05:20+00:00April 24th, 2018|News|

Padova, Italy and Utrecht, the Netherlands, April 24th, 2018 The Istituto Oncologico Veneto (IOV) has acquired MILabs’ latest generation VECTor5CT as a key imaging tool to support its translational oncology mission, entrusted by the Italian Ministry of Health and the Organization of the European Cancer Institutes. Due to its high-resolution imaging capabilities, MILabs’ preclinical Versatile [...]

MILabs’ preclinical imaging annual sales grows again by nearly 50%

2018-09-04T16:08:31+00:00April 9th, 2018|News|

UTRECHT, THE NETHERLANDS, April 6, 2018 MILabs B.V. reported that for the third year in a row, the rapidly-innovating molecular imaging company has continued on its trajectory of strong preclinical imaging systems sales with another year-to-year rise close to 50%.  “The dramatic increase in sales validates the design and functionality of our multimodal imaging platform and confirms [...]